Overview

Sam Katz focuses his practice on investment funds and publicly traded companies. He has extensive experience advising on fund investments and co-investments, leveraging transaction volume to provide market insights and structure deals with the best possible terms for clients. Sam has led numerous fund formations, including credit funds, venture capital funds, litigation finance funds, and special purpose vehicles (SPVs).

In addition to his investment funds work, Sam represents U.S. and foreign publicly traded companies, as well as underwriters, in private placements and public offerings. He regularly counsels clients on compliance with U.S. securities laws, corporate governance matters, and regulatory requirements under the Securities Exchange Act of 1934 and the listing rules of the NYSE and Nasdaq.

With a background spanning private offerings, M&A, credit facilities, and venture capital, Sam brings a holistic business and legal perspective to every transaction, helping clients navigate complex financial and regulatory landscapes.

Honigman Law Israel is a wholly-owned Israeli subsidiary of Honigman LLP. Honigman Law Israel attorneys are qualified under and practice exclusively under U.S. law.

Services

Industries

Experience

Representative Matters

Fund Matters

  • Represented a leading investment manager in numerous fund investments
  • Represented a leading investment manager in numerous co-investments
  • Represented an emerging manager in formation of a credit fund
  • Represented an investment manager in formation of SPVs for investment in pre-IPO investments
  • Represented the investment manager in formation of a Joint Israeli-Chinese Venture Capital Fund
  • Represented Israeli institutions and other investors in commitments of over $100 million to leading venture capital and private equity funds in Israel
  • Represented Israeli fund managers in formation of funds for investment in US real estate
  • Represented $20 million Joint Israel-Korean venture capital fund
  • Represented Leading US asset manager in the formation of funds with over $3 billion in commitments for purchases of distressed securities

Public Company Matters

  • Represented certain shareholders of NYSE-listed Atlas Corp. in its going-private transaction
  • Represented a shareholder of Zevra Pharmaceuticals Inc. in connection with a successful proxy contest
  • Represented NASDAQ-listed NeuroBo Pharmaceuticals Inc. (now known as MetaVia Inc.) in its concurrent private placement and registered direct offering of up to $70m
  • Represented NASDAQ-listed NeuroBo Pharmaceuticals Inc. (now known as MetaVia Inc.) in its concurrent private placement and public offering of $32.3m
  • Represented NASDAQ-listed NeuroBo Pharmaceuticals, Inc. (now known as MetaVia Inc.) in its strategic collaboration to license and develop a portfolio of Dong-A ST Co. Ltd.'s cardio-metabolic therapies
  • Represented NASDAQ-listed Kornit Digital Ltd. in a $87 million secondary offering by the controlling shareholder
  • Represented NASDAQ-listed Kornit Digital Ltd. in a primary and secondary offering of a total of $142 million
  • Represented NASDAQ-listed Kornit Digital Ltd. in a manufacturing agreement and warrant issuance to Amazon.com, Inc.
  • Represented NASDAQ-listed CyberArk Software Ltd. in its acquisition of Cybertinel Ltd.
  • Represented NASDAQ-listed CyberArk Software Ltd. in a $320 million primary and secondary offering
  • Represented Kornit Digital Ltd. in its $73 million initial public offering on NASDAQ
  • Represented TASE-listed (Y.Z) Queenco Ltd. in a tender offer for the shares of Queenco Leisure International Ltd., which involved Israeli, US, and UK securities laws
  • Represented MediWound Ltd. in its $72 million initial public offering on NASDAQ
  • Represented Gazit-Globe Ltd. in its $81 million initial public offering in the US on the NYSE

Prior Experience

  • Ellenoff Grossman & Schole LLP, New York, Of Counsel
  • Meitar Law Offices, Ramat Gan, Israel, Of Counsel
  • Dechert LLP, New York, Associate

Additional Languages

  • Hebrew

Credentials

Education

Admissions

News & Insights

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.